JP2019522662A5 - - Google Patents

Download PDF

Info

Publication number
JP2019522662A5
JP2019522662A5 JP2018568670A JP2018568670A JP2019522662A5 JP 2019522662 A5 JP2019522662 A5 JP 2019522662A5 JP 2018568670 A JP2018568670 A JP 2018568670A JP 2018568670 A JP2018568670 A JP 2018568670A JP 2019522662 A5 JP2019522662 A5 JP 2019522662A5
Authority
JP
Japan
Prior art keywords
formula
compound
production method
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018568670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019522662A (ja
JP6911062B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2017/000012 external-priority patent/WO2018002415A1/en
Publication of JP2019522662A publication Critical patent/JP2019522662A/ja
Publication of JP2019522662A5 publication Critical patent/JP2019522662A5/ja
Application granted granted Critical
Publication of JP6911062B2 publication Critical patent/JP6911062B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018568670A 2016-07-01 2017-06-30 ベムラフェニブの新規な製造方法 Expired - Fee Related JP6911062B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FI20165557 2016-07-01
FI20165557 2016-07-01
FI20165778 2016-10-12
FI20165778 2016-10-12
PCT/FI2017/000012 WO2018002415A1 (en) 2016-07-01 2017-06-30 New processes for the preparation of vemurafenib

Publications (3)

Publication Number Publication Date
JP2019522662A JP2019522662A (ja) 2019-08-15
JP2019522662A5 true JP2019522662A5 (enExample) 2020-07-02
JP6911062B2 JP6911062B2 (ja) 2021-07-28

Family

ID=59416718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018568670A Expired - Fee Related JP6911062B2 (ja) 2016-07-01 2017-06-30 ベムラフェニブの新規な製造方法

Country Status (10)

Country Link
US (1) US10407427B2 (enExample)
EP (1) EP3478684B1 (enExample)
JP (1) JP6911062B2 (enExample)
CA (1) CA3029361A1 (enExample)
ES (1) ES2802476T3 (enExample)
HR (1) HRP20200821T1 (enExample)
HU (1) HUE049682T2 (enExample)
PL (1) PL3478684T3 (enExample)
RS (1) RS60451B1 (enExample)
WO (1) WO2018002415A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2928773T3 (es) 2017-01-17 2022-11-22 Heparegenix Gmbh Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos
DK3860598T3 (da) 2018-10-03 2023-10-16 Jyvaeskylaen Yliopisto Vemurafenib og salte heraf til anvendelse til behandling af enterovirusinfektioner

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303759B1 (it) * 1998-11-17 2001-02-23 Dompe Spa Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
PT1893612E (pt) 2005-06-22 2011-11-21 Plexxikon Inc Derivados de pirrolo [2,3-b]piridina como inibidores de proteína quinase
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
US8779150B2 (en) 2010-07-21 2014-07-15 Hoffmann-La Roche Inc. Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
EA028351B1 (ru) 2013-03-14 2017-11-30 Ратиофарм Гмбх Твердые формы гидрохлорида вемурафениба
WO2015075749A1 (en) 2013-11-22 2015-05-28 Laurus Labs Private Limited Novel processes for the preparation of vemurafenib
CZ2013943A3 (cs) 2013-11-27 2015-06-03 Zentiva, K.S. Krystalické formy vemurafenibu
US10414764B2 (en) 2014-11-29 2019-09-17 Shilpa Medicare Limited Substantially pure vemurafenib and its salts

Similar Documents

Publication Publication Date Title
Birkholz et al. Bite angle effects of diphosphines in C–C and C–X bond forming cross coupling reactions
HRP20190769T1 (hr) Postupak proizvodnje 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina
JP2018527367A5 (enExample)
JP2019522662A5 (enExample)
JP2009541363A5 (enExample)
JP2004189841A5 (enExample)
JP2015517977A5 (enExample)
JP2013508368A5 (enExample)
JP2010539155A5 (enExample)
AU2018260728A1 (en) Process for the preparation of deuterated ethanol from D2
JP2017533234A (ja) ルテニウム触媒作用によるアゾベンゾール類からのビフェニルアミン類の製造方法
JP2019189529A5 (enExample)
CN103664602A (zh) 一种α, β-不饱和羧酸酯类化合物及其制备方法
HRP20200821T1 (hr) Novi procesi za pripremu vemurafeniba
CN118176175A (zh) 含全氟烷基的芳香族化合物的制造方法
SanMartin et al. Mizoroki Heck and Sonogashira Cross‐Couplings Catalyzed by CNC Palladium Pincer Complexes in Organic and Aqueous Media
AR069759A1 (es) Proceso de intermediarios utiles en la preparacion de 5-(etil- dihidro-1-h-inden-2-il) 1h- imidazola
CN111170971B (zh) 一种以邻氯甲苯为原料合成苯并呋喃酮的方法
JP2010511044A5 (enExample)
JP2019112400A5 (enExample)
JP2005511667A5 (enExample)
CN103965057B (zh) 一种腈制备伯胺的方法
JP5155148B2 (ja) 6−[3−(1−アダマンチル)−4−メトキシフェニル]−2−ナフトエ酸の合成方法
CN102311351B (zh) 一种2,4-二甲氧基苄胺的合成方法
JP2002308835A (ja) テルビナフィンの製造方法